The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy in Pancreatic Cancer Models by Altering Ribonucleotide Reductase Subunit-1 (RRM1).
| Image |  |
|---|---|
| Description | scientific article published on 30 July 2015 |
| Author/s |
author: Manuel Rodriguez-Justo |
| Publication date | July 30, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |